Stay updated on Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page.

Latest updates to the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.3 has been added to the footer, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange Detected- Revision: v3.3.2 now appears in the footer, replacing v3.2.0.SummaryDifference0.0%

- Check54 days agoChange DetectedRemoved the government funding operating status notice from the page.SummaryDifference0.3%

- Check69 days agoChange DetectedNew history versions 83–89 were added. There are updates to recruitment status and contacts/locations, expanding the record's audit trail.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded a government funding lapse notice and an operating-status pointer, and updated the version to v3.2.0, replacing the previous v3.1.0.SummaryDifference8%

- Check105 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%

Stay in the know with updates to Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page.